Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | 7 | 3 | 1 | 3 | €1.22 | €3.60 | 194.285% |
| Immunic Inc. | 6 | 2 | 1 | 2 | €1.13 | €5.48 | 385.115% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 1 | €37.20 | €50.00 | 34.409% |
| EyePoint Pharmaceuticals Inc. | 15 | 1 | 0 | 1 | €16.45 | €28.17 | 71.232% |
| Ocular Therapeutix Inc. | 9 | 5 | 0 | 1 | €4.72 | €11.70 | 147.751% |
| Chromadex Corp | 10 | 2 | 1 | 1 | €3.58 | €5.76 | 60.793% |
| Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.20 | €26.92 | 120.684% |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 1 | €11.00 | €21.39 | 94.482% |
| AbbVie Inc. | 18 | 1 | 3 | 1 | €155.60 | €175.79 | 12.974% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 1 | ? | €28.00 | 23.839% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.20 | €12.80 | 204.798% |
| Universal Health Services B | 9 | 4 | 2 | 1 | €147.00 | €159.70 | 8.643% |
| Alkermes plc | 12 | 2 | 3 | 1 | €22.20 | €34.08 | 53.517% |
| Agilent Technologies Inc. | 17 | 3 | 2 | 1 | €123.32 | €133.66 | 8.385% |
| Insmed Inc. | 12 | 1 | 2 | 1 | €23.20 | €43.04 | 85.527% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.38 | €22.78 | 119.415% |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €837.60 | €954.29 | 13.932% |
| Cellectar BioSciences Inc. | 7 | 10 | 3 | 1 | €2.88 | €10.55 | 266.174% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Bruker Corp. | 7 | 2 | 0 | 1 | €74.26 | €84.02 | 13.148% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €344.60 | €359.93 | 4.450% |
| Medpace Holdings Inc | 6 | 0 | 0 | 0 | €344.40 | €399.91 | 16.117% |
| Krystal Biotech | 15 | 0 | 2 | 0 | €148.75 | €166.84 | 12.163% |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €28.46 | €38.55 | 35.460% |
| Innoviva Inc. | 4 | 0 | 2 | 0 | €13.80 | €25.25 | 82.954% |